Dr. Mark Ware is an Associate Professor in Family Medicine and Anesthesia at McGill University, as well as the Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre (MUHC), the Co-Director of the Quebec Pain Research Network and the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids.
Dr. Ware’s primary research interests are in evaluating the safety and effectiveness of medicines derived from cannabis (cannabinoids). He is involved in population-based studies of the impact of pain on the population, and the evaluation of complementary therapies in pain and symptom management. Dr. Ware’s research is supported by the FRQ-S, CIHR, the Louise and Alan Edwards Foundation, the Arthritis Society, ALS Canada, the Canadian HIV Trials Network and grants from pharmaceutical companies.